Morbid Obesity as Early Manifestation of Occult Hypothalamic-Pituitary LCH with Delay in Treatment.

PubWeight™: 0.77^‹?›

🔗 View Article (PMID 26697250)

Published in Case Rep Oncol Med on November 30, 2015

Authors

Jennifer Keates-Baleeiro¹, Marielisa Rincon²

Author Affiliations

1: Department of Pediatric Hematology-Oncology, T.C. Thompson Children's Hospital at Erlanger, 910 Blackford Street, Chattanooga, TN 37403, USA.
2: Department of Endocrinology, T.C. Thompson Children's Hospital at Erlanger, 910 Blackford Street, Chattanooga, TN 37403, USA.

Articles citing this ↘

Clinicopathological features and BRAF(V600E) mutations in patients with isolated hypothalamic-pituitary Langerhans cell histiocytosis. Diagn Pathol (2016) 0.75

Articles cited by this ↗

Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA (2012) 28.69

Assessment of child and adolescent overweight and obesity. Pediatrics (2007) 6.02

Adoption of body mass index guidelines for screening and counseling in pediatric practice. Pediatrics (2010) 1.66

Central nervous system disease in Langerhans cell histiocytosis. J Pediatr (2010) 1.32

Endocrine involvement in pediatric-onset Langerhans' cell histiocytosis: a population-based study. J Pediatr (2004) 1.23

Central diabetes insipidus as the inaugural manifestation of Langerhans cell histiocytosis: natural history and medical evaluation of 26 children and adolescents. J Clin Endocrinol Metab (2011) 1.18

Growth and endocrine disorders in multisystem Langerhans' cell histiocytosis. Clin Endocrinol (Oxf) (2000) 1.02